Trimbow Generic: When Will It Be Available?
This page is aggregated from FDA records, court filings and company announcements. Coded and designed by Dr. Brian Staiger, PharmD, BCPS
Updated October 9, 2026 How we build our data
Trimbow Generic at a Glance
Four quick answers from FDA records and our estimate.
- When is the first generic expected? During 2030 Sometime that year Why then?
- Has the FDA approved a generic? Not yet None in the FDA’s records yet Why not yet?
- When does the last patent end? December 2034 6 patents listed with the FDA Why is a generic expected sooner?
- Can you buy a generic today? Not yet No company lists one for sale
Generic beclomethasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide is expected to be available sometime in 2030. None is for sale yet.
Why 2030?
It is when Trimbow’s patents 10,159,645, 10,806,701, 11,389,401, 11,590,074 and 1 more end. They cover the product’s formulation and a way of using it, and once they end, generics should be able to go on sale as soon as the FDA approves them. We rate it toss-up: still unsettled. Just as likely to slip as to hold.
If Trimbow’s last patent runs to December 2034, how can a generic come sooner?
The patent that runs to December 2034 (10,617,638) covers the product’s formulation and a way of using it. A patent like that protects one way of making or using the medicine, not the medicine itself. A generic company can often make its version a different way or leave that use off its label, or a court can rule the patent invalid or not infringed. That is why the expected month comes before the last protection ends. See the road to a generic
Why hasn’t the FDA approved a generic yet?
That is normal before a launch. The FDA usually can’t give a generic its final approval while a patent or exclusivity still blocks it, so final approval often comes close to the day the generic can be sold. No company holds a “tentative” approval yet either (the FDA’s word for a generic that is ready but still blocked).
Will the generic cost less?
Usually, but no company is recorded as having applied to make one yet, and a single company usually brings only a modest drop. See the price pattern
What should I do now?
Keep taking Trimbow as prescribed. When a generic arrives, your pharmacy may switch you to it automatically, and it may look different. What a generic means for you
Our month is only an estimate based on available information, so we never name a day.
Trimbow by the Numbers
- Reason
- Patent expiresA patent that protects the brand runs out. After that, approved generics can be sold.
- How sure
- Toss-up Still unsettled. Just as likely to slip as to hold.
- Price competition
- None filed yet No filers on record
- Brand sales
- Sales not reported
- FDA approved 2026 May 2026 FDA Orange Book
- Patents listed 6 last runs to December 2034 A generic is expected sooner, sometime in 2030. See why FDA Orange Book
Trimbow’s Road to a Generic
Trimbow has had the market to itself since the FDA approved it in May 2026 (Chiesi Farmaceutici SpA). Its FDA protection (new product) runs to May 2029. Its 6 listed patents run to December 2034.
The first generic of Trimbow is expected sometime in 2030.
Why that month: patents 10,159,645, 10,806,701, 11,389,401, 11,590,074 and 1 more, on the product’s formulation and a way of using it, end then.
Why a Generic Can Come Before December 2034
The last listed patent runs to December 2034, but it covers the product’s formulation and a way of using it, not the medicine itself, which a generic can often work around or challenge. Dr. Brian explains
Each bar runs from the brand’s approval to the day that protection ends. The green band is our projection for the first generic: a month, never a day, because legal dates move and a generic reaches shelves days to weeks after it is allowed. Sources: FDA Orange Book; the expected month from court records and company announcements.
Trimbow Patents and FDA Protections
Every patent and exclusivity the FDA Orange Book lists for Trimbow’s own applications. A protection running past the expected month does not mean the date is wrong: a settlement or a court ruling can let a generic in before a patent ends, and a patent on one formulation or use does not block every generic.
The one that matters for a generic launch: patents 10,159,645, 10,806,701, 11,389,401, 11,590,074 and 1 more, which end in December 2030, the month the first generic is expected. Why the later ones may not hold it back
| Patent | What it covers | Protects until | Status |
|---|---|---|---|
| 10,159,645 Sets the expected month of generic availability | The product’s formulation; a way of using it (U-4538) | December 2030 | Active |
| 10,806,701 Sets the expected month of generic availability | The product’s formulation | December 2030 | Active |
| 11,389,401 Sets the expected month of generic availability | The product’s formulation | December 2030 | Active |
| 11,590,074 Sets the expected month of generic availability | A way of using it (U-4538) | December 2030 | Active |
| 12,357,568 Sets the expected month of generic availability | The product’s formulation; a way of using it (U-4538) | December 2030 | Active |
| 10,617,638 | The product’s formulation; a way of using it (U-4538) | December 2034 | Active |
| Exclusivity | What it means | Ends | Status |
|---|---|---|---|
| New product NP | Three years of protection for a change that needed new clinical studies. | May 2029 | Active |
Source: FDA Orange Book, application 219622. Patent numbers open the patent on Google Patents.
Who Is Lined Up to Make Generic Beclomethasone Dipropionate, Formoterol Fumarate Dihydrate, and Glycopyrronium Bromide
Three steps stand between a brand and a generic you can buy: a company applies to the FDA, the FDA approves it, and the company starts selling it.
Applied to the FDA
No company is recorded as having applied to the FDA to make a generic Trimbow yet.
Approved by the FDA
Not yet. The FDA has not approved a generic beclomethasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide. Final approval often comes close to the day a generic can be sold.
For Sale in Pharmacies
Not yet. No company lists a generic beclomethasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide for sale with the FDA.
Sources: how many companies have applied, from court records and company announcements; approved generics from the FDA Orange Book; tentative approvals from Drugs@FDA; what is for sale from the FDA NDC Directory. The FDA does not disclose an application before it approves it (21 CFR 314.430).
Trimbow Price: What Pharmacies Pay and What Generics Usually Do
What a Generic Could Cost
How we estimate it. The national survey of what pharmacies pay (NADAC) has no recent price for Trimbow, so we cannot show dollars. Here is the FDA’s finding of how far the price pharmacies pay usually falls as generic companies join: about 31% with one company, 44% with two, 73% with four and over 95% with six or more (the typical drop for every drug whose first generic came out from 2015 to 2017).
Median prices pharmacies paid for the generic (invoice prices), compared with the brand’s price before generic entry, from FDA’s 2019 analysis “Generic Competition and Drug Prices”. At the manufacturer’s price FDA found steeper drops (about 39%, 54%, 79% and over 95%), the figures quoted elsewhere on this tracker. A typical pattern, not a price quote for this medicine.
Trimbow Strengths and Forms
| Strength | Form | How it is taken | Approved | Status |
|---|---|---|---|---|
| 0.086MG/INH;0.0049MG/INH;0.0106MG/INH | Aerosol, metered | Inhalation | May 2026 | Prescription reference product |
| 0.172MG/INH;0.0049MG/INH;0.0106MG/INH | Aerosol, metered | Inhalation | May 2026 | Prescription reference product |
Source: FDA Orange Book, Chiesi Farmaceutici SpA. Listed for sale today by Chiesi USA, Inc. (FDA NDC Directory).
Trimbow NDC Codes and Packages
Each Trimbow package sold today has its own NDC, the product number printed on the box and on the pharmacy label. Open one to see that package’s details, what pharmacies pay for it and its patent timeline.
| NDC | Product | Package | Company |
|---|---|---|---|
| 10122-0121-02 | BECLOMETHASONE DIPROPIONATE 172 ug/1 / FORMOTEROL FUMARATE 4.9 ug/1 / GLYCOPYRROLATE 10.6 ug/1 aerosol, metered | canister of 120 aerosols | Chiesi USA, Inc. |
| 10122-0590-02 | BECLOMETHASONE DIPROPIONATE 172 ug/1 / FORMOTEROL FUMARATE 4.9 ug/1 / GLYCOPYRROLATE 10.6 ug/1 aerosol, metered | canister of 120 aerosols | Chiesi USA, Inc. |
| 10122-0120-02 | BECLOMETHASONE DIPROPIONATE 86 ug/1 / FORMOTEROL FUMARATE 4.9 ug/1 / GLYCOPYRROLATE 10.6 ug/1 aerosol, metered | canister of 120 aerosols | Chiesi USA, Inc. |
| 10122-0460-02 | BECLOMETHASONE DIPROPIONATE 86 ug/1 / FORMOTEROL FUMARATE 4.9 ug/1 / GLYCOPYRROLATE 10.6 ug/1 aerosol, metered | canister of 120 aerosols | Chiesi USA, Inc. |
Source: the FDA NDC Directory, current listings only. Only packages sold under Trimbow’s own FDA approval (NDA 219622) are listed, never a generic. Some codes belong to companies that repackage Trimbow: it is the same medicine in a different package.
What a Generic Trimbow Means for You
Nothing Changes Until It Is in Pharmacies
Until a generic is actually for sale, keep filling Trimbow as usual. When one arrives, there is nothing you need to sign up for.
Your Pharmacy May Switch You Automatically
Every state lets pharmacists fill a brand-name prescription with an FDA-approved generic rated as equivalent to it, and about 19 states require them to, unless your prescriber writes “dispense as written” or “brand medically necessary” on the prescription. Some states ask the pharmacist to tell you, or to get your OK first. A study of every state’s law has the details.
It Will Probably Look Different
US trademark law does not let a generic look exactly like the brand, so the color, shape or markings usually change. The active ingredient, strength and form are the same. An “authorized generic,” made by or for the brand’s own company, can look identical. The FDA explains.
Your Insurance May Change Too
Once a lower-cost version is available, many insurance plans charge more for the brand, or stop covering it. Your plan’s drug list (formulary) says how.
Until a generic is on US pharmacy shelves, be careful with websites that offer “generic Trimbow”. The FDA warns that unlicensed online pharmacies sell counterfeit and unapproved medicines; its BeSafeRx page shows how to check a pharmacy.
Questions people ask about Trimbow
Is there a generic for Trimbow right now?
No. As of October 9, 2026 no generic beclomethasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide is listed for sale in the FDA NDC Directory.
When will Trimbow go generic?
Sometime in 2030 is the expected window, and that is toss-up but not certain. It is when Trimbow’s patents 10,159,645, 10,806,701, 11,389,401, 11,590,074 and 1 more end. They cover the product’s formulation and a way of using it, and once they end, generics should be able to go on sale as soon as the FDA approves them. The last listed patent runs to December 2034, but it covers the product’s formulation and a way of using it, not the medicine itself, which a generic can often work around or challenge.
Will generic beclomethasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide be the same as Trimbow?
Yes in the ways that matter: the same active ingredient, strength and form, with proof that it reaches your blood the same way. Inactive ingredients can differ, which is why some people notice a different look or taste.
How much will the generic cost?
Nobody can say for sure before launch. No company is recorded as having applied to the FDA to make one yet, and a single company usually brings only a modest drop.
Has the FDA approved a generic Trimbow?
Not yet. The FDA Orange Book lists no approved generic version of Trimbow.
When does the Trimbow patent expire?
The FDA Orange Book lists 6 patents for Trimbow; the last runs to December 2034. The one behind the expected month is patents 10,159,645, 10,806,701, 11,389,401, 11,590,074 and 1 more, which end in December 2030. A patent date is not the launch date: settlements and court rulings often bring a generic earlier, and FDA approval or a company’s own plans can make it later. The expected window on this page (Sometime in 2030) weighs all of that.
Changes to This Projection
- First generic expected Sometime in 2030 on this month’s schedule. A line is added here whenever a monthly update moves the month, the reason or how sure it is.
Every change to the expected month is logged here with the month we saw it.
Also Going Generic
- Sodium ThiosulfateSodium ThiosulfateDuring 2028
- Eliquis SprinkleApixaban2031 to 2032
- OmlontiOmidenepag IsopropylJanuary 2035
- ArikayceAmikacin SulfateMay 2035
- VoxzogoVosoritide2039 to 2040
- JavadinClonidine HydrochlorideJuly 2042
About Trimbow
- Generic name beclomethasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide
- How it is taken Inhaled
- Company Chiesi Farmaceutici SpA
- Hard to copy Inhalers, injectables, patches and other hard-to-copy products. Fewer companies attempt them and dates slip more often.
- More drugs Brand-name drugs starting with T
- Have a question? A pharmacist answers, free. Ask about Trimbow
Sources. The expected month: FDA Paragraph IV Patent Certifications list, federal court records, company announcements and securities filings (settlement dates, launch plans, sales). The record on this page: FDA Orange Book, Drugs@FDA (tentative approvals), FDA NDC Directory, FDA, Generic Competition and Drug Prices (2019). Updated October 9, 2026. Information, not medical advice.